Validation of Perception of Some Nigerians on the Origin and Use of Phyto-remedies in Management of Covid 19; An Overview of Social Media Respondents
Keywords:COVID 19, Phytochemicals, SARS-COV 2, MERS-CoV
Communication in Physical Sciences 2020, 6(1): 649-657
In 2019, a novel respiratory tract disease causing microorganism, SARS-COV 2 was reported with origin traced to some species of bat in Wuhan-China. The first case of this disease was reported in Nigeria on the 27th of February 2020. A lot of speculations were posted on social media on the origin, management and existence of COVID 19. This study is designed to assess the perception of some Nigerians on COVID 19 and to validate the claim on the use of some plants formulation for the treatment of this disease. An online view of the perception and speculation of some Nigerians were obtained from the surveymonkey URL https://www.surveymonkey.com/r/7T9KNSB. 10 structured questions were designed and administered to respondent with the aim of drawing information on the origin of COVID 19, public perception on the management of COVID 19 with phytomedicines and prevention approach against COVID 19. The validation of the origin of SARS-COV 2 virus and its management was sustained by available literature. This study reveals that little or no knowledge on the origin of SARS-COV 2 was demonstrated by the respondents. The claim management approach of the COVID 19 did not correspond with the existing literature relating the activities of the plants phytochemical constituents on various viral species.
Abhishek, N. & Dhan, P. (2008). Chemical constituents and biological activities of turmeric (Curcuma longa L.) - A review. Journal of Food Science and Technology, 45, 2, pp. 109–116
Ao, S., Shi-Yu, C. , Xiao-Yu, X., Ren-You, G., Guo-Yi, T., Harold, C., Vuyo, M. &Hua-Bin L.
(2019). Bioactive compounds and biological functions of garlic (Allium sativum L.). MPDI-Foods, 8, 246, doi.org/10.3390/foods8070246
Augustina, A., Heather, J. B., Victor, M. C., Stefan, M. K., Michael, O., Evans, E. N., Ebenezer K.B., Priscilla A., Olivia, A., Benjamin, M., Samuel, O., Yau, A. S. Elizabeth, K.V. K., Peter, H. C. L., Elena, V. G., Elisabeth, K. V., Kalko., C. R., Antje, S., Florian, G., Peter, V., Christian, D. & Jan, F. D. (2013). Human betacoronavirus 2c EMC/2012–related viruses in bats, Ghana and Europe. Emerging Infectious Diseases, 19, 3, pp. DOI: 10.3201/eid1903.121503
Cori, L., Bianchi, F., Cadum, R. & Anthonj, C. (2020). Risk Perception and COVID-19. International Journal of Environmental Research and Public Health, 17, 3114, doi:10.3390/ijerph17093114
Chaturvedi, D., Shrivastava, R. & Raj, S. N. (2016). Basketful benefit of citrus limon.
International Research Journal of Pharmacy. 7, 6, DOI: 10.7897/2230-8407.07653
David J C. (2020). Coronavirus disease 2019 (COVID-19). treatment and management. available at https://emedicine.medscape.com/ article/2500114-treatment date visited 16/6/2017
Centers for Disease Control and Prevention. (2020). How COVID-19 Spreads. from CDC –
Coronavirus Disease (2019). (COVID-19): https://www.cdc.gov/coronavirus/2019- ncov/prepare/transmission.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019- ncov%2Fabout%2Ftransmission.html. Retrieved February 1, 2020,
Gao, J, Tian, Z &Yang, X. (2020). Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience Trends. 14, 1, pp. 72-73.
Rothan, H. A. & Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmun. 109:102433. doi:10.1016/ j.jaut.2020.102433
Lai, C. C., Shi, T. P., Ko, W. C., Tang, H. J. & Hsueh, P. R. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International journal of antimicrobial agents, 55, 3, 105924. https://doi.org/10.1016/j.ijantimicag.2020.105924
Liu, Y., Li, J. & Feng, Y. (2020). Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China. Critical Care, 24, 1, 56, doi:10.1186/s13054-020-2786-x
Li, F. (2016). Structure, Function, and Evolution of Coronavirus Spike Proteins. Annual Review of Virology, 3, 1, pp. 237- 261. doi:10.1146/annurev-virology-110615-042301
Li, S., Yuan, W., Deng, G., Wang, P., Yang, P. & Aggarwal B.B. (2011). Chemical composition and product quality control of turmeric (Curcuma longa L.). Pharmaceutical Crops, 2, pp. 28-54.
Luo, H., Tang, Q. L., Shang, Y. X., Liang, S. B., Yang, M. & Robinson, N, (2020) .Can Chinese medicine be used for prevention of corona virus disease (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chinese Journal of Integrated Medicine, 26, 4, pp. 243-250.
Mele, M. A. (2019), Bioactive compounds and biological activity of ginger. J. Multidisciplinary Sciences, 1, 1, pp. 1-7.
Molina, E. G., Domínguez-Perles, R.., Moreno, D. A. & Cristina, G. (2020). Natural bioactive compounds of Citrus limon for food and health. Journal of Pharmaceutical and Biomedical Analysis, 51, 2, pp. 327-45
Muhammad, A. S., Suliman, K., Abeer, K., Nadia, B. & Rabeea, S. (2020). COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research, 91–98
Nigeria Centre for Disease Control (NCDC, 2020). National Strategy to Scale Up Access to Coronavirus Disease Testing in Nigeria
NCDC( 2020). First case of corona virus disease confirmed in Nigeria. Available online @ https://ncdc.gov.ng/news/227/first-case-of-corona-virus-disease-confirmed-in-nigeria visited on 27/6/2020
Ohiaa, C., Bakarey, A. S. & Ahmad, T. (2020). COVID-19 and Nigeria: putting the realities in context. International Journal of Infectious Diseases. 95, pp. 279–281.
Peng, L., Yang, W., Zhang, D., Zhuge, C. & Hong L. (2020). Epidemic analysis of COVID-19 in China by dynamical modeling. MedRXIV. doi.org/10.1101/2020.02.16.20023465
Presidential Task Force on covid 19 (2020). Implementation Guide for Lockdown Policy Section I: Guidance for Lockdown Enforcement. Available online @ https://statehouse. gov.ng/ wp-content/uploads/ 2020/04/PTF-COVID-19-Guidance-on-implementation-of-lockdown-policy-FINAL.docx-2.pdf visited on 27/6/2020
Rabby, M. I. I (2020). Current Drugs with Potential for Treatment of COVID-19: A Literature Review. Journal of Pharmacology and Pharmaceutical Sciences, 23, pp. 58 – 64
She, J., Jiang, J., Ye, L., Hu, L., Bai, C. & Song Y. (2020). 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clinical and Translational Medicine. 9:19, doi.org/10.1186/s40169-020-00271-z
Singletary, K.W. (2010). Ginger: An Overview of Health Benefits Nutrition Today 45, 4, pp. 171-183
Stephen, A. L., Kyara, H. G., Oifang, B., Forrest, K. J., Qulu, Z., Hannah, R. M., Andrew, S.
A., Nicholas, G. R. & Justin L. (2020). The incubation period of coronavirus disease 2019 (covid-19) from publicly reported confirmed cases: estimation and application. Annals of Internal Medicine 172, 9, pp. 577-582.
Tamara, S. A., Umber, Z., Rafia,, R., Muhammad, I. M., Sadique, S., Shafaq, N., Tamadour, S. A. & Reham, W. T. (2018). Lemon as a source of functional and medicinal ingredient: A review. International Journal of Chemical and Biochemical Sciences. 14, pp. 55-61
Vergara-Jimenez, M., Almatrafi, M. M. & Fernandez, M. L. (2017). Bioactive Components in
Moringa Oleifera Leaves Protect against Chronic Disease. MDPI-Antioxidant. 6, 91, doi:10.3390/antiox6040091
World Health Organization (2020). Clinical Management of Covid. 19. Interim Guidance, 27th May, 2020. Available online at file:///C:/Users/pc/ Downloads/WHO-2019-nCoV-clinical-2020.5-eng.pdf date 16/6/2020
World Health Organization (2020). COVID-19 Public Health Emergency of International Concern
(PHEIC) Global research and innovation forum. Available online @ https://www.who.int /publications/m/item/covid-19-public-health-emergency-of-international-concern-(pheic)-global-research-and-innovation-forum visited 23/6/2020
Zou, L, Ruan, F., Huang, M., Liang, L., Huang, H. & Hong Z. (2020). SARS-CoV-2 Viral
load in upper respiratory specimens of infected patients. New England Journal of Medicine, 382, pp. 1177-1179
Copyright (c) 2010 The Journal and the author
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.